KAINOS MEDICINE, INC.
284620·KOSDAQ·5 grantsAmendments merged
- Shares granted, cumulative
- 2,221,000shares
- Next lockup release
- —
Against the share price
At the 2026-08-18 close- Shares with a reason to exercise
- None
- Sellable right now
- None
- Unrealized paper gain (to the employees)
- —
Potential dilution
Shares by strike price
- ₩6,409201K shares
- ₩4,4061M shares
- ₩4,018500K shares
- ₩3,95550K shares
- ₩2,275425K shares
- ₩1,087Latest price
Every strike price is above the latest close, so no options currently have a reason to be exercised.
Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.
Share price vs. strike price
A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.
- Strike ₩4,4061M shares
- Strike ₩4,018500K shares
- Strike ₩2,275425K shares
- Strike ₩6,409201K shares
Recipients by role
- Registered director6 people24%
- Unregistered officer3 people1%
- Other · unknown26 people75%
Sorted from the relation text written in the filings (35 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers. This company reported many recipients under a lumped label such as “executives and employees”, or left the field blank, so the breakdown is limited.
Shares granted by year
Cumulative grants per recipient
12 named · 20 withheld| Recipient | Shares, cumulative | Average strike | Exercisable | Paper gain |
|---|---|---|---|---|
| 525,00019.7% | ₩4,132 | 525,000 | — | |
| 500,00018.7% | ₩3,955 | 500,000 | — | |
| 250,0009.4% | ₩4,406 | 250,000 | — | |
| 250,0009.4% | ₩2,275 | 250,000 | — | |
| 175,0006.6% | ₩4,692 | 175,000 | — | |
| 172,5006.5% | ₩4,406 | 172,500 | — | |
| 138,0005.2% | ₩4,406 | 138,000 | — | |
| 52,5002.0% | ₩2,472 | 52,500 | — | |
| 50,0001.9% | ₩6,409 | 50,000 | — | |
| 10,0000.4% | ₩6,409 | 10,000 | — |
Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.
Grant history · lockup schedule
Exercisable shares over time
It rises on the day a lockup ends and falls on the day an exercise window closes. Options actually exercised are not subtracted, because only executives have to report them.
20231 grant · 200,500 shares
- Granted2023-03-14
- Exercise starts2026-03-14
- Exercise ends2036-03-14
- Shares granted
- 200,500shares
- Strike price
- 6,409KRW
- Grant method
- New share issuance, Treasury shares, Cash settlement
- Approved by
- Board of directors
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20221 grant · 425,000 shares
- Granted2022-03-14
- Exercise starts2025-03-14
- Exercise ends2035-03-13
- Shares granted
- 425,000shares
- Strike price
- 2,275KRW
- Grant method
- New share issuance, Treasury shares, Cash settlement
- Approved by
- Board of directors
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20213 grants · 1,595,500 shares
- Granted2021-03-31
- Exercise starts2024-03-31
- Exercise ends2034-03-30
- Shares granted
- 50,000shares
- Strike price
- 3,955KRW
- Grant method
- New share issuance, Treasury shares, Cash settlement
- Approved by
- Shareholders' meeting
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
- Granted2021-03-15
- Exercise starts2024-03-15
- Exercise ends2034-03-15
- Shares granted
- 500,000shares
- Strike price
- 4,018KRW
- Grant method
- New share issuance, Treasury shares, Cash settlement
- Approved by
- Board of directors
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
- Granted2021-01-15
- Exercise starts2024-01-15
- Exercise ends2034-01-14
- Shares granted
- 1,045,500shares
- Strike price
- 4,406KRW
- Grant method
- New share issuance, Treasury shares, Cash settlement
- Approved by
- Board of directors
Below the strike priceShare price below the strike — no reason to exercise[Amended] Report on grant of stock options
Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.